CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 862 enrolled
Drug / intervention
CVD Integrated Risk Testdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05294419
NCT05294419N/ACompleted

The Healthcare Evaluation of Absolute Risk Testing Study: A Multi-centre, Single Arm, Pragmatic Study in Primary Care Setting

Genomics PLC·interventional·Posted Mar 24, 2022·Updated Dec 8, 2025

In Brief

A clinical study evaluating CVD Integrated Risk Test for Cardiovascular Diseases. Completed, enrolled 862 participants across 1 site.

Detailed Summary

The aim of this study is to demonstrate the integration and use of cardiovascular disease (CVD) integrated risk tool (IRT) in an environment as close to real-world as possible. This study will recruit participants of both biological sexes and any ancestry or background who require and are eligible for a CVD risk assessment as part of the NHS Health Check. Those aged 45-64 years are most likely to benefit from CVD IRT and will be included in the study, as they are more likely to be asymptomatic but also derive most benefit from preventative measures. The study will be conducted in GP surgeries as the CVD IRT will have its greatest impact if incorporated into primary care practice for early identification of patients at highest risk. This study is a device performance evaluation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 24, 2022
Enrollment StartNov 4, 2021
Primary CompletionAug 31, 2022
Study CompletionSep 30, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.3 years ago

Interventions

CVD Integrated Risk Testdevice

CVD IRT (Cardiovascular Integrated Risk Tool)